scPharmaceuticals, Inc.

( )
SCPH After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 0.93%54.040.9%$2015.04m
JNJJohnson & Johnson -0.82%165.210.7%$968.47m
ABBVAbbVie, Inc. -1.62%133.021.9%$895.75m
MRKMerck & Co., Inc. -0.69%80.730.7%$855.87m
BMYBristol-Myers Squibb Co. -0.17%64.611.0%$688.01m
LLYEli Lilly & Co. -0.76%243.201.1%$618.76m
AZNAstraZeneca Plc 1.16%60.171.0%$241.82m
NVSNovartis AG -0.75%88.180.2%$194.25m
GSKGlaxoSmithKline Plc -1.77%44.880.2%$162.29m
NVONovo Nordisk A/S -1.86%95.480.1%$152.14m
VTRSViatris, Inc. -0.54%14.640.0%$140.27m
RGENRepligen Corp. -0.59%188.466.7%$99.30m
IMMXImmix Biopharma, Inc. -4.24%5.420.0%$85.02m
ALLKAllakos, Inc. -3.37%7.180.0%$84.68m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.87%116.040.0%$72.25m

Company Profile

scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include furosemide, used as parenteral diuretic in treating heart failure and ceftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.